International consensuses and guidelines on etiology, diagnosis, treatment, and future developments of neovascular age-related macular degeneration (nAMD) by the Asia-Pacific Vitreo-retina Society (APVRS), the Asia-Pacific Ocular Imaging Society (APO

Neovascular age-related degeneration (nAMD) is one of the leading causes of visual impairment in older populations in the developed world. With the aging population, the incidence of nAMD is growing globally. Despite advancements in diagnostic investigations and treatment modalities over the past three decades, there remains considerable controversies in the pathogenesis, classification and optimal management strategies. An international panel of 31 experts from 11 countries/regions prepared and voted on consensus statements in five key areas: (1) etiology controversies; (2) diagnosis controversies; (3) treatment controversies; (4) future development controversies; and (5) healthcare deliveries controversies. Among the 31 consensus statements, 28 (90.3 %) have achieved over 75 % agreement. These statements can provide a practical guide for ophthalmologists to provide the optimal care of patients with nAMD and for planning future research priorities in order to address the unmet needs in nAMD.

Authors

Institutions

Publication Details

Journal
Asia-Pacific Journal of Ophthalmology
Published
2025-08-29
DOI
https://doi.org/10.1016/j.apjo.2025.100242
Primary Topic
Retinal Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

International consensuses and guidelines on etiology, diagnosis, treatment, and future developments of neovascular age-related macular degeneration (nAMD) by the Asia-Pacific Vitreo-retina Society (APVRS), the Asia-Pacific Ocular Imaging Society (APO

Youxin Chen, Danny Siu‐Chun Ng, Dennis S.C. Lam, Timothy Y. Y. Lai et al.
Asia-Pacific Journal of Ophthalmology
Retinal Diseases and Treatments
article

International consensuses and guidelines on etiology, diagnosis, treatment, and future developments of neovascular age-related macular degeneration (nAMD) by the Asia-Pacific Vitreo-retina Society (APVRS), the Asia-Pacific Ocular Imaging Society (APO

Youxin Chen, Danny Siu‐Chun Ng, Dennis S.C. Lam, Timothy Y. Y. Lai, Li Jia Chen, Andrew Chang, Fumi Gomi, Susan S. Huang, Robyn H. Guymer, Tommy Kwan Hin Fong, Muna Bhende, Mahesh Shanmugam, Mariko Sasaki, Sobha Sivaprasad, Xinyuan Zhang, Tien Yin Wong, Jay Kumar Chhablani, Yi‐Ting Hsieh, Keiko Kataoka, Chui Ming Gemmy Cheung, Annabelle A. Okada, Rajendra S. Apte, Judy E. Kim, Gregg T. Kokame, Xiaoxin Li, Adrian Koh, Srinivas R. Sadda, Lalit Verma, Nishant Radke, Voraporn Chiakitmongkol
article en

Abstract

Neovascular age-related degeneration (nAMD) is one of the leading causes of visual impairment in older populations in the developed world. With the aging population, the incidence of nAMD is growing globally. Despite advancements in diagnostic investigations and treatment modalities over the past three decades, there remains considerable controversies in the pathogenesis, classification and optimal management strategies. An international panel of 31 experts from 11 countries/regions prepared and voted on consensus statements in five key areas: (1) etiology controversies; (2) diagnosis controversies; (3) treatment controversies; (4) future development controversies; and (5) healthcare deliveries controversies. Among the 31 consensus statements, 28 (90.3 %) have achieved over 75 % agreement. These statements can provide a practical guide for ophthalmologists to provide the optimal care of patients with nAMD and for planning future research priorities in order to address the unmet needs in nAMD.

Asia-Pacific Journal of OphthalmologyVol. 14(5)
Sankara Nethralaya (IN), Beijing Tongren Hospital (CN), The University of Sydney (AU), Moorfields Eye Hospital NHS Foundation Trust (GB), University of Hawaii System (US), Tokyo Medical University (JP), University of Pittsburgh (US), Chinese University of Hong Kong (HK), Kyorin University (JP), Xiamen University (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Keio University (JP), Washington University in St. Louis (US), Singapore National Eye Center (SG), Hong Kong Eye Hospital (CN), Peking Union Medical College Hospital (CN), Sydney Hospital (AU), National Institute for Health and Care Research (GB), University of Illinois Chicago (US), Doheny Eye Institute (US), Centre for Eye Research Australia (AU), Eye & Retina Surgeons (SG), Singapore Eye Research Institute (SG), Chinese University of Hong Kong, Shenzhen (CN), National Taiwan University Hospital (TW), Shenzhen Luohu People's Hospital (CN), Beijing Tsinghua Chang Gung Hospital (CN), Eye Hospital in Bangalore (IN), Centre for Sight (IN), University College London (GB), Chiang Mai University (TH), Hyogo University (JP), The University of Texas Southwestern Medical Center (US), Tsinghua University (CN)
Good health and well-being
Openalex Percentile: Top 66%
Retinal Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.